Melissa M. Hardesty

Oncology

3851 Piper Street
Suite U264
Anchorage, AK 99508

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Systemic Treatment of Ovarian Cancer Recurrence: ASCO Living Guideline, Version 2026.1.0.

Systemic Treatment of Ovarian Cancer Recurrence: ASCO Living Guideline, Version 2026.1.0.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: July 13, 2026

Circulating tumor DNA monitoring in ovarian cancer patients receiving PARPi maintenance therapy: Can we further personalize treatment?

Circulating tumor DNA monitoring in ovarian cancer patients receiving PARPi maintenance therapy: Can we further personalize treatment?

Journal: Gynecologic oncology

Published: August 25, 2025

A phase 2 trial of niraparib plus bevacizumab maintenance therapy following first-line platinum-based chemotherapy with bevacizumab in advanced ovarian cancer: final analysis and overall survival results from OVARIO.

A phase 2 trial of niraparib plus bevacizumab maintenance therapy following first-line platinum-based chemotherapy with bevacizumab in advanced ovarian cancer: final analysis and overall survival results from OVARIO.

Journal: Gynecologic oncology

Published: April 07, 2025

Entrectinib use in a platinum-refractory mucinous ovarian cancer harboring a NTRK3 gene fusion.

Entrectinib use in a platinum-refractory mucinous ovarian cancer harboring a NTRK3 gene fusion.

Journal: Gynecologic oncology reports

Published: February 15, 2023

Management of chemotherapy hypersensitivity reactions and desensitization: An SGO clinical practice statement.

Management of chemotherapy hypersensitivity reactions and desensitization: An SGO clinical practice statement.

Journal: Gynecologic oncology

Published: December 31, 2022

Doubling down on the future of gynecologic oncology: The SGO future of the profession summit report.

Doubling down on the future of gynecologic oncology: The SGO future of the profession summit report.

Journal: Gynecologic oncology

Published: December 22, 2022

OVARIO phase II trial of combination niraparib plus bevacizumab maintenance therapy in advanced ovarian cancer following first-line platinum-based chemotherapy with bevacizumab.

OVARIO phase II trial of combination niraparib plus bevacizumab maintenance therapy in advanced ovarian cancer following first-line platinum-based chemotherapy with bevacizumab.

Journal: Gynecologic oncology

Published: March 18, 2022

Survival sex and trafficked women: The politics of re-presenting and speaking about others in anti-oppressive qualitative research.

Survival sex and trafficked women: The politics of re-presenting and speaking about others in anti-oppressive qualitative research.

Journal: Qualitative social work : QSW : research and practice

Published: August 03, 2019

A case of severe encephalitis while on PD-1 immunotherapy for recurrent clear cell ovarian cancer.

A case of severe encephalitis while on PD-1 immunotherapy for recurrent clear cell ovarian cancer.

Journal: Gynecologic oncology reports

Published: February 12, 2018

The end of life costs for Medicare patients with advanced ovarian cancer.

The end of life costs for Medicare patients with advanced ovarian cancer.

Journal: Gynecologic oncology

Published: September 11, 2017

Conservative Management of Invasive Placentation: Two Cases with Different Surgical Approaches.

Conservative Management of Invasive Placentation: Two Cases with Different Surgical Approaches.

Journal: AJP reports

Published: June 14, 2016

The Cost of Initial Care for Medicare Patients With Advanced Ovarian Cancer.

The Cost of Initial Care for Medicare Patients With Advanced Ovarian Cancer.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: September 30, 2015

Showing 1-12 of 13

Last Updated: 09/26/2026